Cell BioEngines

Cell BioEngines is a biotechnology company aimed at improving cell therapies for cancer patients by developing new technologies. The business strategy focuses on advancing its proprietary Stem SPACE™ platform technology for the expansion of umbilical cord blood stem cells and their differentiation into specific immune cell states with high clinical potential and economies of scale. Through this approach, the company has created a pipeline of development-stage assets for revenue streams.